SEARCH

SEARCH BY CITATION

Figure S1. Percentage of patients (and 95% confidence intervals) with at least one INR < 2 in the different time periods after coumarin initiation.

Figure S2. Percentage of patients (and 95% confidence intervals) with at least one INR > 3.5 in the different time periods after coumarin initiation.

Figure S3. Percentage of patients (and 95% confidence intervals) with at least one INR > 6 in the different time periods after coumarin initiation.

Figure S4. Risk of under- or overanticoagulation during the first month of coumarin treatment and  combined VKORC1/CYP2C9 genotypes.

Table S1. Characteristics of included phenprocoumon users.

FilenameFormatSizeDescription
JTH_12007_sm_TableS1-FigS1-S4.doc81KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.